Komori
Other Disclosures4886ASKA Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Notice of obtaining the highest-level three-star Eruboshi certification as a company promoting women’s advancement

The subsidiary Asuka Pharmaceutical Co., Ltd. obtained the third and highest level of Eruboshi Certification, the three-star level, as a company with outstanding initiatives promoting women's advancement.

Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
3
Third level (three stars)
Wording
Definitive
How definitive the wording is.

Announced details

Eruboshi Certification
Applicable field (uses covered by this announcement)

Promotion of women's advancement and women's participation in professional life

Launch date31 July 2026 (certification acquisition date; actual)
Relationship between the counterparty and the company
ASKA Pharmaceutical Holdings Co.,Ltd.4886
Relationship with the Company

Asuka Pharmaceutical Co., Ltd. obtained the certification. Capital, personnel and business relationships: not disclosed.

CounterpartyTokyo Labour Bureau of the Ministry of Health, Labour and Welfare

The Tokyo Labour Bureau, Ministry of Health, Labour and Welfare, is the government agency that grants Eruboshi Certification.

Award/certification name

Eruboshi Certification, highest-level third level (three stars)

Awarding / certifying body

Tokyo Labour Bureau of the Ministry of Health, Labour and Welfare

Location (as indicated in this announcement)

Minato-ku, Tokyo (Asuka Pharmaceutical headquarters)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredEruboshi Certification
CounterpartyTokyo Labour Bureau of the Ministry of Health, Labour and Welfare
Counterparty overviewThe Tokyo Labour Bureau, Ministry of Health, Labour and Welfare, is the government agency that grants Eruboshi Certification.
Relationship with the CompanyAsuka Pharmaceutical Co., Ltd. obtained the certification. Capital, personnel and business relationships: not disclosed.
Launch date31 July 2026 (certification acquisition date; actual)
Applicable areaPromotion of women's advancement and women's participation in professional life
Award/certification nameEruboshi Certification, highest-level third level (three stars)
Awarding / certifying bodyTokyo Labour Bureau of the Ministry of Health, Labour and Welfare
LocationMinato-ku, Tokyo (Asuka Pharmaceutical headquarters)
Items this document does not state (9)
Contract ValueOffering priceContract DateRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company received high evaluations for the implementation of initiatives promoting women's advancement and met the certification criteria in all five assessment categories: recruitment, continued employment, working hours and other work practices, the ratio of women in management positions, and diverse career paths.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of obtaining the highest-level three-star Eruboshi certification as a company promoting women’s advancement | ASKA Pharmaceutical Holdings Co.,Ltd. (4886) timely disclosure | Komori